NCT03978481

Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,700 (actual)
• Sponsor: Seoul National University Bundang Hospital · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

In this study, we will observe the long-term survival rate, overall mortality rate, gastric cancer specific mortality rate, and the incidence rate of metachronous cancer in patients who received subtotal gastrectomy, with or without Helicobacter pylori eradication.

Detailed description

In this study, we will observe the long-term survival rate, overall mortality rate, gastric cancer specific mortality rate, and the incidence rate of metachronous cancer in patients who received subtotal gastrectomy, with or without Helicobacter pylori eradication. In addition, we will analyze the correlation between the incidence and survival rate of this type of stomach cancer by comparing smoking, gastric cancer direct family history, disease stage (TNM staging), the histologic type of stomach cancer (intestinal, diffuse, mixed), and the surgical method (Billoth I, Billoth II) as well as the infection and eradication status of H. pylori.

Conditions

• Gastric Cancer

Interventions

Type	Name	Description
COMBINATION_PRODUCT	Helicobacter pylori eradication (combination therapy)	Antibiotic eradication therapy (triple or quadriple regimen)

Timeline

• Start date: 2019-01-30
• Primary completion: 2020-01-30
• Completion: 2020-04-30
• First posted: 2019-06-07
• Last updated: 2024-11-29

Locations

1 site across 1 country: South Korea